vimarsana.com

Latest Breaking News On - Senior neurology analyst - Page 1 : vimarsana.com

GlobalData : TauRx's HMTM could become first oral DMT targeting Tau for Alzheimer's disease, says GlobalData -March 08, 2024 at 11:12 pm EST

08 Mar, 2024 TauRx s HMTM could become first oral DMT targeting Tau for Alzheimer s disease, says GlobalData Share Print.

United-kingdom
Philippa-salter
International-conference-on-alzheimer
Senior-neurology-analyst
Drugs-database

Biogen needs Leqembi to be successful following discontinuation of Aduhelm, says GlobalData

Biogen needs Leqembi to be successful following discontinuation of Aduhelm, says GlobalData
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Germany
China
Italy
Spain
Japan
France
Eli-lilly
Pippa-salter
Medicaid-services
International-conference-on-alzheimer
Us-centers-for-medicare

Relmada Therapeutics anti-depressant - rapid and sustained effects

Relmada Therapeutics, Inc. has announced rapid and sustained effects of an anti-depressant in patients with major depressive disorders (MDD).

Philippa-salter
Cedric-ogorman
Senior-neurology-analyst
Relmada-therapeutics
Axsome-therapeutic-auvelity
Clinical-development
Preclinical-research
Atient-centricity
Pis-active-pharmaceutical-ingredients-
Major-depressive-disorder
Anti-depressant

Could first anti-tau therapy be approved for Alzheimer's?

Could first anti-tau therapy be approved for Alzheimer's?
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Canada
Claude-wischik
Pippa-salter
Taurx-therapeutic
Senior-neurology-analyst
Professor-claude-wischik

vimarsana © 2020. All Rights Reserved.